Herceptin News and Research

RSS
EU-sponsored TumAdoR project targets relationship between immune system and cancer growth

EU-sponsored TumAdoR project targets relationship between immune system and cancer growth

Breast cancer cells masquerade as neurons begin to form ultimately-deadly brain tumors

Breast cancer cells masquerade as neurons begin to form ultimately-deadly brain tumors

MIT receives $90M from Ludwig Cancer Research to strengthen interdisciplinary approach to cancer research

MIT receives $90M from Ludwig Cancer Research to strengthen interdisciplinary approach to cancer research

UCLA scientists receive $21M grant to conduct groundbreaking clinical trials on stem cell science

UCLA scientists receive $21M grant to conduct groundbreaking clinical trials on stem cell science

Scientists bring stem cell science directly to patients

Scientists bring stem cell science directly to patients

Study: Taxol and Herceptin highly effective for lower-risk breast cancer patients

Study: Taxol and Herceptin highly effective for lower-risk breast cancer patients

Women with HER2+ breast tumors who receive combination therapy unlikely to have cancer recur

Women with HER2+ breast tumors who receive combination therapy unlikely to have cancer recur

Biocon receives regulatory approval for biosimilar product, trastuzumab

Biocon receives regulatory approval for biosimilar product, trastuzumab

Generex Biotechnology provides update on Phase II trial of AE37 breast cancer vaccine

Generex Biotechnology provides update on Phase II trial of AE37 breast cancer vaccine

Array BioPharma reports net loss of $0.13 per share for first quarter of fiscal 2014

Array BioPharma reports net loss of $0.13 per share for first quarter of fiscal 2014

FDA grants accelerated approval of Perjeta for people with HER2-positive early stage breast cancer

FDA grants accelerated approval of Perjeta for people with HER2-positive early stage breast cancer

HER2-positive breast cancer patients could now benefit from Herceptin SC injection

HER2-positive breast cancer patients could now benefit from Herceptin SC injection

Researchers identify potentially treatable subtype of pancreatic cancer

Researchers identify potentially treatable subtype of pancreatic cancer

Roche's Herceptin formulation wins EU approval for treatment of HER2-positive breast cancer

Roche's Herceptin formulation wins EU approval for treatment of HER2-positive breast cancer

Combining drugs that target AXL and ErbB receptors could offer better way to fight tumors

Combining drugs that target AXL and ErbB receptors could offer better way to fight tumors

ImmunoGen reports net loss of $21.9 million in Q4 2013

ImmunoGen reports net loss of $21.9 million in Q4 2013

Research opens potential new avenue for cancer treatment

Research opens potential new avenue for cancer treatment

UCLA's Jonsson Comprehensive Cancer Center named one of nation's top 12 cancer centers

UCLA's Jonsson Comprehensive Cancer Center named one of nation's top 12 cancer centers